rs11263943 - FTLP18 - GRIK3

Magnitude 4.5 · 1 study on file

Reported associations

  • Item-level analyses reveal genetic heterogeneity in neuroticism - Unknown journal (n.d.) · Unknown authors · PubMed 29500382

    ABSTRACT: Genome-wide association studies (GWAS) of psychological traits are generally conducted on (dichotomized) sums of items or symptoms (e.g., case-control status), and not on the individual items or symptoms themselves. We conduct large-scale GWAS on 12 neuroticism items and observe notable and replicable variation in genetic signal between items. Within samples, genetic correlations among the items range between 0.38 and 0.91 (mean rg = .63), indicating genetic heterogeneity in the full item set. Meta-analyzing the two samples, we identify 255 genome-wide significant independent genomic regions, of which 138 are item-specific. Genetic analyses and genetic correlations with 33 external traits support genetic differences between the items. Hierarchical clustering analysis identifi


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • genetic findings and personalized mental health strategy Moderate

    GRIK3 rs11263943 shows strong GWAS association with neuroticism and environmental stress sensitivity

    discuss genetic predisposition, preventive approaches, and treatment options if symptoms develop

Lifestyle

  • stress management and emotional resilience practices Moderate

    GRIK3 variants associated with higher neuroticism and stress sensitivity; structured approaches mitigate emotional reactivity

    implement mindfulness, cognitive behavioral therapy, or similar evidence-based approach; 20-30 minutes daily

Screening

  • mental health assessment for anxiety and depression Moderate

    Genetic predisposition to neuroticism and environmental stress sensitivity associates with elevated risk of anxiety and depressive disorders

    baseline mental health screening with standardized tool; ongoing monitoring if symptoms develop